Med. praxi. 2022;19(5):320-323 | DOI: 10.36290/med.2022.048

Patient with neuromuscular junction disease in a general practitioner's office

MUDr. Jana Junkerová1, 2, MUDr. Eva Kovalová1
1 Neurologická klinika Fakultní nemocnice Ostrava
2 Lékařská fakulta Ostravské univerzity, Ostrava

Myasthenia gravis is the most important disease caused by a failure of signal transmission from the nerve fiber to the muscle. The most common target of the pathological antibody response is the acetylcholine receptor on the postsynaptic side of the neuromuscular disc. The prevalence of myasthenia gravis is 8-15/100 000, so it is not a rare disease. The article briefly describes the peculiarities of clinical manifestations, recommendations for effective diagnosis, its difficulties and treatment options for this disease. We want to point out the differences between myasthenic pathological fatigue and weakness, as opposed to non-specific fatigue, which is often described by patients. The practice of general practitioners can significantly increase and accelerate the detection of myasthenia gravis and reduce the risk of acute decompensation in treated myasthenics. In short, we present clinical units arising from a disorder of the presynaptic part of the neuromuscular disc. The work complements the comprehensive information on peripheral nerve disorders and myopathies, which were published in previous issues of the journal.

Keywords: myasthenia gravis, neuromuscular disc, acetylcholine receptor, acetylcholinesterase, pathological fatigue, Lambert­‑Eaton myasthenic syndrome, botulism.

Accepted: November 22, 2022; Published: November 29, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Junkerová J, Kovalová E. Patient with neuromuscular junction disease in a general practitioner's office. Med. praxi. 2022;19(5):320-323. doi: 10.36290/med.2022.048.
Download citation

References

  1. Ambler Z, Bednařík J, Růžička E, et al. Klinická neurologie, část speciální II. Praha: Triton; 2010.
  2. Keller O. Obecná elektromyografie. Praha: Triton; 1999.
  3. Piťha et al. Myasthenia gravis a ostatní poruchy nervosvalového přenosu. Praha: Maxdorf; 2010.
  4. Jakubíková M, Piťha J. Současný pohled na imunopatogenezi myasthenia gravis. Cesk Slov Neurol N. 2015;78/111(6): 649-654.
  5. Abenroth DC, Smith AG, Greenlee JE, et al. Lambert­‑Eaton myasthenic syndrome: Epidemiology and therapeutic response in the national veterans affairs population. Muscle Nerve. 2017;56(3):421-426. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.